Literature DB >> 26139991

Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression.

Guang-Yun Yang1, Sen Guo1, Cong-Ying Dong1, Xian-Qiang Wang1, Bing-Yang Hu1, Yang-Feng Liu1, Yong-Wei Chen1, Jun Niu1, Jia-Hong Dong1.   

Abstract

AIM: To detect the mechanism by which colon tumor escapes the growth constraints imposed on normal cells by cell crowding and dense pericellular matrices.
METHODS: An immunohistochemical study of integrin αvβ6 and matrix metalloproteinase-9 (MMP-9) was performed on tissue microarrays of 200 spots, including 100 cases of colon tumors.
RESULTS: High immunoreactivity for αvβ6 (73.7%; 28/38) and MMP-9 (76.5%; 52/68) was observed in invasive tumor portions. Furthermore, the effects of integrin αvβ6 on tumor invasive growth in nude mice were detected. Tumor invasive growth and high expression of both αvβ6 and MMP-9 were only seen in tumors resulting from WiDr cells expressing αvβ6 in the tumorigenicity assay. Flow cytometry was applied to analyze αvβ6 expression in colon cancer WiDr and SW480 cells. The effects of cell density on αvβ6 expression and MMP-9 secretion were also detected by Biotrak MMP-9 activity assay and gelatin zymography assay. High cell density evidently enhanced αvβ6 expression and promoted MMP-9 secretion compared with low density.
CONCLUSION: Integrin αvβ6 sustains and promotes tumor invasive growth in tumor progression via a self-perpetuating mechanism. Integrin ανβ6-mediated MMP-9 secretion facilitates pericellular matrix degradation at high cell density, which provides the basis of invasive growth.

Entities:  

Keywords:  Colonic neoplasms; Integrin αvβ6; Invasive growth; Matrix metalloproteinase-9

Mesh:

Substances:

Year:  2015        PMID: 26139991      PMCID: PMC4481440          DOI: 10.3748/wjg.v21.i24.7457

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Integrin-mediated signalling of gelatinase B secretion in colon cancer cells.

Authors:  J Niu; X Gu; J Turton; C Meldrum; E W Howard; M Agrez
Journal:  Biochem Biophys Res Commun       Date:  1998-08-10       Impact factor: 3.575

2.  PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6.

Authors:  Jian Wang; Jingjing Wu; Jianguo Hong; Rong Chen; Kesen Xu; Weibo Niu; Cheng Peng; Enyu Liu; Jiayong Wang; Song Liu; Michael Agrez; Jun Niu
Journal:  Cancer Lett       Date:  2011-06-24       Impact factor: 8.679

3.  The cytoplasmic extension of the integrin β6 subunit regulates epithelial-to-mesenchymal transition.

Authors:  Carlin Lee; Casey Lee; Stacey Lee; Amanda Siu; Daniel M Ramos
Journal:  Anticancer Res       Date:  2014-02       Impact factor: 2.480

4.  Induction of matrix metalloproteinase gene expression in an endothelial cell line by direct interaction with malignant cells.

Authors:  Yuki Hasebe; Kiyoshi Egawa; Motoko Shibanuma; Kiyoshi Nose
Journal:  Cancer Sci       Date:  2007-01       Impact factor: 6.716

5.  The expression of integrin alpha(v)beta6 promotes the epithelial cell morphology and suppresses invasive behavior in transformed oral keratinocytes.

Authors:  Seiki Mogi; Dongmin Dang; Carter Van Waes; Duncan Ellis; Amha Atakilit; Daniel M Ramos
Journal:  Anticancer Res       Date:  2005 Mar-Apr       Impact factor: 2.480

6.  Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.

Authors:  Ki-Jae Park; Hong-Jo Choi; Mee-Sook Roh; Hyuk-Chan Kwon; Choongrak Kim
Journal:  Dis Colon Rectum       Date:  2005-08       Impact factor: 4.585

7.  TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression.

Authors:  Aram F Hezel; Vikram Deshpande; Stephanie M Zimmerman; Gianmarco Contino; Brinda Alagesan; Michael R O'Dell; Lee B Rivera; Jay Harper; Scott Lonning; Rolf A Brekken; Nabeel Bardeesy
Journal:  Cancer Res       Date:  2012-07-11       Impact factor: 12.701

8.  A new prognostic staging system for rectal cancer.

Authors:  Hideki Ueno; Ashley B Price; Kay H Wilkinson; Jeremy R Jass; Hidetaka Mochizuki; Ian C Talbot
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

9.  Overexpression of the alphavbeta6 integrin in endometrial cancer.

Authors:  Jonathan L Hecht; Brian M Dolinski; Humphrey A Gardner; Shelia M Violette; Paul H Weinreb
Journal:  Appl Immunohistochem Mol Morphol       Date:  2008-12

10.  Therapeutic targeting of integrin αvβ6 in breast cancer.

Authors:  Kate M Moore; Gareth J Thomas; Stephen W Duffy; Jane Warwick; Rhian Gabe; Patrick Chou; Ian O Ellis; Andrew R Green; Syed Haider; Kellie Brouilette; Antonio Saha; Sabari Vallath; Rebecca Bowen; Claude Chelala; Diana Eccles; William J Tapper; Alastair M Thompson; Phillip Quinlan; Lee Jordan; Cheryl Gillett; Adam Brentnall; Shelia Violette; Paul H Weinreb; Jane Kendrew; Simon T Barry; Ian R Hart; J Louise Jones; John F Marshall
Journal:  J Natl Cancer Inst       Date:  2014-06-28       Impact factor: 13.506

View more
  12 in total

Review 1.  Evaluating Trastuzumab in the treatment of HER2 positive breast cancer.

Authors:  Ryan Jaques; Sam Xu; Antonios Matsakas
Journal:  Histol Histopathol       Date:  2020-04-23       Impact factor: 2.303

Review 2.  Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis.

Authors:  Alexandra Desnoyers; Carlos González; Pedro Pérez-Segura; Atanasio Pandiella; Eitan Amir; Alberto Ocaña
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

3.  Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).

Authors:  Zequn Li; Pengfei Lin; Chao Gao; Cheng Peng; Song Liu; Huijie Gao; Ben Wang; Jiayong Wang; Jun Niu; Weibo Niu
Journal:  Tumour Biol       Date:  2015-11-07

4.  SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer.

Authors:  Eiki Ichihara; David Westover; Catherine B Meador; Yingjun Yan; Joshua A Bauer; Pengcheng Lu; Fei Ye; Amanda Kulick; Elisa de Stanchina; Robert McEwen; Marc Ladanyi; Darren Cross; William Pao; Christine M Lovly
Journal:  Cancer Res       Date:  2017-04-17       Impact factor: 12.701

5.  Small-animal SPECT/CT imaging of cancer xenografts and pulmonary fibrosis using a 99mTc-labeled integrin αvβ6-targeting cyclic peptide with improved in vivo stability.

Authors:  Hao Liu; Liquan Gao; Xinhe Yu; Lijun Zhong; Jiyun Shi; Bing Jia; Nan Li; Zhaofei Liu; Fan Wang
Journal:  Biophys Rep       Date:  2018-11-02

6.  Integrin αvβ6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8-Mediated MAPK/ERK Signaling.

Authors:  Pengwei Yan; Huanfeng Zhu; Li Yin; Lijun Wang; Peng Xie; Jinjun Ye; Xuesong Jiang; Xia He
Journal:  Transl Oncol       Date:  2018-03-21       Impact factor: 4.243

Review 7.  Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy.

Authors:  Ping-Hsiu Wu; Abayomi Emmanuel Opadele; Yasuhito Onodera; Jin-Min Nam
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639

8.  ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 Expression.

Authors:  Yurie Soejima; Miho Takeuchi; Nao Miyamoto; Motoji Sawabe; Toshio Fukusato
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

Review 9.  Exploring the Role of RGD-Recognizing Integrins in Cancer.

Authors:  Markus Nieberler; Ute Reuning; Florian Reichart; Johannes Notni; Hans-Jürgen Wester; Markus Schwaiger; Michael Weinmüller; Andreas Räder; Katja Steiger; Horst Kessler
Journal:  Cancers (Basel)       Date:  2017-09-04       Impact factor: 6.639

10.  Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.

Authors:  Naomi O Hodgins; Wafa' T Al-Jamal; Julie T-W Wang; Rebecca Klippstein; Pedro M Costa; Jane K Sosabowski; John F Marshall; John Maher; Khuloud T Al-Jamal
Journal:  J Control Release       Date:  2017-04-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.